Annual FCF
-$71.16 M
-$5.91 M-9.05%
31 December 2023
Summary:
Immunic annual free cash flow is currently -$71.16 million, with the most recent change of -$5.91 million (-9.05%) on 31 December 2023. During the last 3 years, it has fallen by -$24.89 million (-53.80%). IMUX annual FCF is now -806.64% below its all-time high of -$7.85 million, reached on 31 December 2011.IMUX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$20.85 M
-$3.64 M-21.16%
30 September 2024
Summary:
Immunic quarterly free cash flow is currently -$20.85 million, with the most recent change of -$3.64 million (-21.16%) on 30 September 2024. Over the past year, it has dropped by -$3.50 million (-20.15%). IMUX quarterly FCF is now -348.16% below its all-time high of -$4.65 million, reached on 31 December 2018.IMUX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$76.26 M
-$3.50 M-4.81%
30 September 2024
Summary:
Immunic TTM free cash flow is currently -$76.26 million, with the most recent change of -$3.50 million (-4.81%) on 30 September 2024. Over the past year, it has dropped by -$4.18 million (-5.80%). IMUX TTM FCF is now -1531.14% below its all-time high of -$4.67 million, reached on 31 March 2013.IMUX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMUX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.1% | -20.1% | -5.8% |
| 3 y3 years | -53.8% | -18.4% | -3.6% |
| 5 y5 years | -62.6% | -248.2% | -182.8% |
IMUX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -53.8% | +14.6% | -52.6% | +13.1% | -18.8% | +16.2% |
| 5 y | 5 years | -148.8% | +14.6% | -248.2% | +28.1% | -182.8% | +16.2% |
| alltime | all time | -806.6% | +14.6% | -348.2% | +28.1% | -1531.1% | +16.2% |
Immunic Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$20.85 M(+21.2%) | -$76.26 M(+4.8%) |
| June 2024 | - | -$17.21 M(-28.3%) | -$72.76 M(-3.7%) |
| Mar 2024 | - | -$24.00 M(+69.1%) | -$75.55 M(+6.2%) |
| Dec 2023 | -$71.16 M(+9.1%) | -$14.19 M(-18.2%) | -$71.16 M(-1.3%) |
| Sept 2023 | - | -$17.36 M(-13.2%) | -$72.07 M(+5.4%) |
| June 2023 | - | -$20.00 M(+1.9%) | -$68.39 M(+6.6%) |
| Mar 2023 | - | -$19.62 M(+29.9%) | -$64.18 M(-1.6%) |
| Dec 2022 | -$65.26 M(-21.7%) | -$15.10 M(+10.5%) | -$65.26 M(-11.6%) |
| Sept 2022 | - | -$13.67 M(-13.4%) | -$73.85 M(-5.1%) |
| June 2022 | - | -$15.79 M(-23.7%) | -$77.80 M(-14.5%) |
| Mar 2022 | - | -$20.69 M(-12.7%) | -$91.03 M(+9.3%) |
| Dec 2021 | -$83.30 M(+80.0%) | -$23.70 M(+34.5%) | -$83.30 M(+13.2%) |
| Sept 2021 | - | -$17.62 M(-39.3%) | -$73.59 M(+8.3%) |
| June 2021 | - | -$29.02 M(+124.0%) | -$67.94 M(+41.0%) |
| Mar 2021 | - | -$12.96 M(-7.4%) | -$48.20 M(+4.2%) |
| Dec 2020 | -$46.27 M(+61.8%) | -$13.99 M(+16.9%) | -$46.27 M(+20.0%) |
| Sept 2020 | - | -$11.97 M(+28.9%) | -$38.57 M(+18.3%) |
| June 2020 | - | -$9.28 M(-15.9%) | -$32.59 M(-5.0%) |
| Mar 2020 | - | -$11.03 M(+75.4%) | -$34.31 M(+20.0%) |
| Dec 2019 | -$28.60 M(-34.6%) | -$6.29 M(+5.0%) | -$28.60 M(+6.1%) |
| Sept 2019 | - | -$5.99 M(-45.5%) | -$26.96 M(-21.4%) |
| June 2019 | - | -$11.00 M(+106.6%) | -$34.32 M(-4.3%) |
| Mar 2019 | - | -$5.32 M(+14.4%) | -$35.86 M(-18.1%) |
| Dec 2018 | -$43.76 M | -$4.65 M(-65.1%) | -$43.76 M(-10.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$13.35 M(+6.4%) | -$49.14 M(+8.3%) |
| June 2018 | - | -$12.54 M(-5.2%) | -$45.38 M(+5.2%) |
| Mar 2018 | - | -$13.22 M(+31.8%) | -$43.12 M(+5.0%) |
| Dec 2017 | -$41.08 M(+13.1%) | -$10.03 M(+4.6%) | -$41.08 M(+2.0%) |
| Sept 2017 | - | -$9.59 M(-6.8%) | -$40.27 M(+3.7%) |
| June 2017 | - | -$10.28 M(-8.1%) | -$38.85 M(+3.8%) |
| Mar 2017 | - | -$11.18 M(+21.3%) | -$37.43 M(+3.0%) |
| Dec 2016 | -$36.33 M(-30.5%) | -$9.22 M(+13.0%) | -$36.33 M(-0.3%) |
| Sept 2016 | - | -$8.16 M(-8.0%) | -$36.45 M(-10.3%) |
| June 2016 | - | -$8.87 M(-12.0%) | -$40.64 M(-15.7%) |
| Mar 2016 | - | -$10.08 M(+7.9%) | -$48.19 M(-7.8%) |
| Dec 2015 | -$52.29 M(+23.8%) | -$9.34 M(-24.4%) | -$52.29 M(-2.1%) |
| Sept 2015 | - | -$12.35 M(-24.8%) | -$53.39 M(+1.6%) |
| June 2015 | - | -$16.42 M(+15.8%) | -$52.55 M(+13.6%) |
| Mar 2015 | - | -$14.18 M(+35.9%) | -$46.24 M(+9.5%) |
| Dec 2014 | -$42.23 M(+40.2%) | -$10.44 M(-9.3%) | -$42.23 M(-0.0%) |
| Sept 2014 | - | -$11.51 M(+13.8%) | -$42.24 M(+7.1%) |
| June 2014 | - | -$10.11 M(-0.6%) | -$39.45 M(+10.7%) |
| Mar 2014 | - | -$10.17 M(-2.6%) | -$35.63 M(+18.2%) |
| Dec 2013 | -$30.13 M(+217.0%) | -$10.44 M(+19.7%) | -$30.13 M(+53.0%) |
| Sept 2013 | - | -$8.72 M(+38.6%) | -$19.69 M(+79.5%) |
| June 2013 | - | -$6.29 M(+34.6%) | -$10.97 M(+134.6%) |
| Mar 2013 | - | -$4.67 M | -$4.67 M |
| Dec 2012 | -$9.51 M(+21.1%) | - | - |
| Dec 2011 | -$7.85 M | - | - |
FAQ
- What is Immunic annual free cash flow?
- What is the all time high annual FCF for Immunic?
- What is Immunic annual FCF year-on-year change?
- What is Immunic quarterly free cash flow?
- What is the all time high quarterly FCF for Immunic?
- What is Immunic quarterly FCF year-on-year change?
- What is Immunic TTM free cash flow?
- What is the all time high TTM FCF for Immunic?
- What is Immunic TTM FCF year-on-year change?
What is Immunic annual free cash flow?
The current annual FCF of IMUX is -$71.16 M
What is the all time high annual FCF for Immunic?
Immunic all-time high annual free cash flow is -$7.85 M
What is Immunic annual FCF year-on-year change?
Over the past year, IMUX annual free cash flow has changed by -$5.91 M (-9.05%)
What is Immunic quarterly free cash flow?
The current quarterly FCF of IMUX is -$20.85 M
What is the all time high quarterly FCF for Immunic?
Immunic all-time high quarterly free cash flow is -$4.65 M
What is Immunic quarterly FCF year-on-year change?
Over the past year, IMUX quarterly free cash flow has changed by -$3.50 M (-20.15%)
What is Immunic TTM free cash flow?
The current TTM FCF of IMUX is -$76.26 M
What is the all time high TTM FCF for Immunic?
Immunic all-time high TTM free cash flow is -$4.67 M
What is Immunic TTM FCF year-on-year change?
Over the past year, IMUX TTM free cash flow has changed by -$4.18 M (-5.80%)